Cancer pill could replace IV drips in new trial
NCT ID NCT06021600
Summary
This study is testing if a new pill form of the cancer drug cladribine works similarly to the standard version given through an IV. It involves 40 adults with specific types of leukemia. The main goal is to find the right pill dose that delivers the same amount of drug into the body as the IV infusion.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.